Novartis Ag (NVS) Acquisitions (2009 - 2026)

Novartis Ag has disclosed Acquisitions across 14 years of filings, most recently posting -$23.0 million for Q2 2026.

• In Q2 2026, Acquisitions rose 81.89% year-over-year to -$23.0 million; the TTM figure through Jun 2026 stood at -$12.2 billion (down 210.18% YoY), while the FY2025 annual figure was -$147.0 million, up 96.34% from the prior year.
• Acquisitions came in at -$23.0 million for Q2 2026 at Novartis Ag, up from -$12.0 billion in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $1.0 million in Q3 2025 to a low of -$12.0 billion in Q1 2026.
• Average Acquisitions over 5 years is -$1.6 billion, with a median of -$105.5 million recorded in 2023.
• Year-over-year, Acquisitions plunged 3851.19% in 2024 and jumped 101.72% in 2025.
• Over 5 years, Acquisitions stood at -$59.0 million in 2022, then plunged by 42.37% to -$84.0 million in 2023, then tumbled by 407.14% to -$426.0 million in 2024, then soared by 70.19% to -$127.0 million in 2025, then jumped by 81.89% to -$23.0 million in 2026.
• Per Business Quant data, the three most recent Acquisitions figures were -$23.0 million in Q2 2026, -$12.0 billion in Q1 2026, and -$127.0 million in Q4 2025.